Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors.
about
Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.Identification of drug-resistant subpopulations in canine hemangiosarcoma.Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients.Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives.Interactions between CXCR4 and CXCL12 promote cell migration and invasion of canine hemangiosarcoma.Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma.Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers.Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.Strong radioprotective FGF1 signaling down-regulates proliferative and metastatic capabilities of the angiosarcoma cell line, ISOS-1, through the dual inhibition of EGFR and VEGFR pathways.Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
P2860
Q36286330-CE7DE80F-DE1F-419D-9B2B-9BBD16EE3189Q38963363-02C104EB-BB2D-4AFA-9B2E-20C6F161AE0DQ38967069-4FA432F7-547F-49F4-8FD9-97D2D89E6BF0Q41469380-0BC4BFE8-8236-4DEA-BF19-7C0E44AC40BAQ44409594-F0E61CF3-5424-4819-83BA-196C7DBF89A5Q44859548-A082E834-80FB-496F-803A-BEF4E8B5E16AQ47101799-CFB4DD27-B661-4903-8352-AFA2FD5A6A76Q47299200-A6C5D7C8-7464-4A9D-B881-DDE3381E2739Q47448276-F06AE46D-5AF8-4FF7-B77B-2F3E64A92735Q51738705-CEE51A87-CD13-472D-B3D6-28F2DC142A67Q55011926-35E0EC38-AFF5-4FFB-BF50-AD78406CFFBCQ55192373-8FD89A61-2955-4B9A-9D2F-2193BF950240Q57069094-B60409A9-2661-4973-8E43-54BBF38D7337
P2860
Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hemangiosarcoma and its cancer ...... actor and urokinase receptors.
@en
Hemangiosarcoma and its cancer ...... actor and urokinase receptors.
@nl
type
label
Hemangiosarcoma and its cancer ...... actor and urokinase receptors.
@en
Hemangiosarcoma and its cancer ...... actor and urokinase receptors.
@nl
prefLabel
Hemangiosarcoma and its cancer ...... actor and urokinase receptors.
@en
Hemangiosarcoma and its cancer ...... actor and urokinase receptors.
@nl
P2093
P2860
P356
P1476
Hemangiosarcoma and its cancer ...... actor and urokinase receptors.
@en
P2093
Aric M Frantz
Brandi H Gorden
Daniel A Vallera
Erin B Dickerson
Jill T Schappa
P2860
P304
P356
10.1002/IJC.28187
P577
2013-04-25T00:00:00Z